Evidence map›Paper›PMID 30228234›Full record

ArticleBlood2018

Shiro Tara, Yusuke Isshiki, Yaeko Nakajima-Takagi, Motohiko Oshima, Kazumasa Aoyama, Tomoyuki Tanaka, Daisuke Shinoda, Shuhei Koide, Atsunori Saraya, Satoru Miyagi and 5 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 53 citations in OpenAlex.

  1. The Mutational Landscape of Acute Myeloid Leukemia and Its Impact.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Cancers · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Science advances · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis.Journal of experimental & clinical cancer research : CR · 2022
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Shiro TaraDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yusuke IsshikiDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yaeko Nakajima-TakagiDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Motohiko OshimaDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kazumasa AoyamaDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Tomoyuki TanakaDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Daisuke ShinodaDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Shuhei KoideDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Atsunori SarayaDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Satoru MiyagiDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ichiro ManabeDepartment of Disease Biology and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hirotaka MatsuiDepartment of Molecular Laboratory Medicine, Kumamoto University, Kumamoto, Japan.
Haruhiko KosekiLaboratory for Developmental Genetics, RIKEN Research Center for Integrative Medical Sciences, Yokohama, Japan; and.
Vivian J BardwellDepartment of Genetics, Cell Biology, and Development, Masonic Cancer Center and Developmental Biology Center, University of Minnesota, Minneapolis, MN.
Atsushi IwamaDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.ORCID 0000-0001-9410-8992
Chiba University · JPKumamoto University · JPRIKEN Center for Integrative Medical Sciences · JPUniversity of Minnesota · US

Funding

Molecular Basis of Action of the Putative Oncogene BCL6R01CA071540 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BARDWELL, VIVIAN J · 2002 to 2012
$3.0M
Control of Trophoblast Differentiation in Placental DevelopmentR01HD084459 · NICHD · UNIVERSITY OF MINNESOTA · PI BARDWELL, VIVIAN J · 2016 to 2020
$1.7M
NCI NIH HHS R01 CA071540NICHD NIH HHS R01 HD084459
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amino Acid SequenceExonsMyelodysplastic SyndromesRepressor ProteinsSequence DeletionAnimalsCCAAT-Enhancer-Binding ProteinsHematopoietic Stem CellsHomeodomain ProteinsMiceMice, KnockoutPrecursor T-Cell Lymphoblastic Leukemia-LymphomaTumor Suppressor Protein p53Bcor protein, mouseCCAAT-Enhancer-Binding ProteinsCEBPA protein, mouseHomeodomain ProteinsHoxA proteinRepressor ProteinsTrp53 protein, mouseTumor Suppressor Protein p53

Identifiers

PMID30228234
PMCPMC6450057
OpenAlexW2890508019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.